An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  AJP - Renal Physiology

• Publication date

  1998-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajprenal.1998.275.2.F278PMID 9691019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet.

  1996cited by this paper
• E2F-1 functions in mice to promote apoptosis and suppress proliferation.

  1996cited by this paper
• A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

  1995cited by this paper
• In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer.

  1995cited by this paper
• Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.

  1994cited by this paper
• Distinct nuclear proteins competing for an overlapping sequence of cyclic adenosine monophosphate and negative regulatory elements regulate tissue-specific mouse renin gene expression.

  1993cited by this paper
• Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo.

  1993cited by this paper
• A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter

  1993cited by this paper
• The pathobiology of the mesangium.

  1992cited by this paper
• Activation of the Mouse Proliferating Cell Nuclear Antigen Gene Promoter by Adenovirus Type 12 E1A Proteins

  1992cited by this paper
• Retinoblastoma protein switches the E2F site from positive to negative element

  1992cited by this paper
• Direct in vivo gene introduction into rat kidney.

  1992cited by this paper
• Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.

  1992cited by this paper
• Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression.

  1992cited by this paper
• Cell cycle regulation of the human cdc2 gene.

  1992cited by this paper
• Paradoxical transcriptional activation of rat liver cytochrome P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16 alpha-carbonitrile: analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes.

  1992cited by this paper
• A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.

  1992cited by this paper
• E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

  1992cited by this paper
• Animal cell cycles and their control.

  1992cited by this paper
• Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.

  1992cited by this paper
• A transcriptional tryst

  1991cited by this paper
• Retinoblastoma. A transcriptional tryst.

  1991cited by this paper
• The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein.

  1991cited by this paper
• Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.

  1991cited by this paper
• The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.

  1991cited by this paper
• Molecular mechanism of tissue-specific regulation of mouse renin gene expression by cAMP. Identification of an inhibitory protein that binds nuclear transcriptional factor.

  1991cited by this paper
• The E2F transcription factor is a cellular target for the RB protein.

  1991cited by this paper
• Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.

  1990cited by this paper
• Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression.

  1990cited by this paper
• Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.

  1990cited by this paper
• Regulation of gene expression with double-stranded phosphorothioate oligonucleotides.

  1990cited by this paper
• Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.

  1989cited by this paper
• Cationic liposome-mediated transfection

  1989cited by this paper
• E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.

  1989cited by this paper
• Multiple c‐myb transcript cap sites are variously utilized in cells of mouse haemopoietic origin.

  1987cited by this paper
• Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation

  1986cited by this paper
• Improved methods for culturing rat glomerular cells.

  1984cited by this paper

• Cold Shock Proteins Mediate GN with Mesangioproliferation.

  2016cites this paper
• MicroRNA-let-7a promotes E2F-mediated cell proliferation and NFκB activation in vitro

  2013cites this paper
• Regulation of Gene Expression through Photocaged Oligonucleotides.

  2013cites this paper
• Stratégie du leurre moléculaire en thérapie génique : ciblage de facteurs de transcription par un minicercle d'ADN multisites et étude de l'interaction entre l'ADN platiné et NF-κB

  2012cites this paper
• Photochemical control of DNA decoy function enables precise regulation of nuclear factor κB activity.

  2011cites this paper
• E2F-1 as an anticancer drug target

  2011cites this paper
• Induction of endogenous γ-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence

  2009cites this paper
• Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy.

  2009cites this paper
• Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease

  2007cites this paper
• E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis.

  2006cites this paper
• The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.

  2005cites this paper
• Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells

  2005cites this paper
• Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model.

  2004cites this paper
• Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo

  2004cites this paper
• Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation

  2004cites this paper
• Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy

  2004cites this paper
• Molecular mechanism of cell injury.

  2003cites this paper
• Therapeutic potential of decoy oligonucleotides strategy in cardiovascular diseases

  2003cites this paper
• An E2F site in the 5′‐promoter region contributes to serum‐dependent up‐regulation of the human proliferating cell nuclear antigen gene

  2003cites this paper
• E2F1 as a Target: Promoter-Driven Suicide and Small Molecule Modulators

  2003cites this paper
• Molecular strategy using cis-element ‘decoy’ of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model

  2002cites this paper
• Decoy oligonucleotide characterization of GATA-4 transcription factor in hypertrophic agonist induced responses of cardiac myocytes

  2002cites this paper
• Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide.

  2002cites this paper
• Targeted gene therapy for rat glomerulonephritis using HVJ‐immunoliposomes

  2002cites this paper
• Inhibition of TNF-α, Induced Cytokine and Adhesion Molecule

  2001cites this paper
• Photo-cross-linked oligonucleotide duplex as a decoy-DNA for inhibition of restriction endonuclease activity.

  2001cites this paper
• A non-nucleotide-bridged DNA decoy inhibits renal epithelial nitric oxide synthase expression.

  2000cites this paper
• Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.

  2000cites this paper
• Targeted disruption of stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven T(H)2 cell response.

  2000cites this paper
• In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis.

  2000cites this paper
• Growth factor pathways in proliferative glomerulonephritis.

  2000cites this paper
• Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.

  2000cites this paper
• Element in Exon 1 of the CD28 Gene Oligonucleotide Decoys to the Regulatory Inhibition of CD28 Expression by

  1999cites this paper
• Roles of E2F1 in mesangial cell proliferation in vitro.

  1999cites this paper
• Inhibition of CD28 expression by oligonucleotide decoys to the regulatory element in exon 1 of the CD28 gene.

  1999cites this paper
• Regulation of E2F: a family of transcription factors involved in proliferation control.

  1999cites this paper
• The cell cycle and drug discovery: the promise and the hope.

  1999cites this paper
• Regulation of mesangial cell proliferation.

  1999cites this paper